Skip to content

ALMAPHARMA

Active Private limited companyfounded 1985active for 41 yearsDe Pannelaan 15, 8660 De PanneKBO/BCE: BE 0427.782.965 #4 oldest company in De Panne, Wholesale and retail trade sector

Lifetime

20 annual accounts with figures on one time axis, 39 filings since 1987
peak of €253,762 in 2023
€223,954▲ 7.6%
peak of €87,267 in 2020
€28,272▼ 36.6%
peak of €308,575 in 2022
€256,263▲ 12.4%
€259,302▲ 71.8%
peak of 2.2 FTE in 2024
2.2 FTEunchanged
Board2 names since 1985
1 director
Documentsfilings and deeds
07-04-2026115 days before the deadline
2025abbreviated format
Result from €44,586 to €28,272Equity from €227,991 to €256,263Debts from €150,926 to €259,302Investments €57,982

Key points

from the 2025 annual accounts

Equity

€256,263 ▲ 12.4%

ALMAPHARMA has made a profit in every financial year since 2006.

Turnover

≈ €1.1m estimated

The abbreviated format states no turnover.

Investments

€127,249 6.3 times depreciation
2021202220242025

Green is investment, beige is depreciation. Machinery stands 3303.9% higher than in 2024.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,389 companies had the same profile as ALMAPHARMA has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,389 companies, not a prediction for ALMAPHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director,
  • deed of 10-01-2014
  • deed of 10-01-2014
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0427782965
Company renamed from APOTHEEK to ALMAPHARMA Gazette deed
and act as permanent representatives Gazette deed
1 director appointed, 1 resignation resigns · appointed · acts as permanent representative · General meeting of 30-03-2022 · Gazette deed
All 51 events

Comparable companies

same main activity, similar in size and age
Company
ALMAPHARMA De Panne €515,565 €223,954 49.7% 2.2
NAVEAU-SMEETS Lint €552,659 €237,388 49.3% 2.1
APOTHEEK HOOGMARTENS Leuven €564,667 €206,773 66.1% 2.1
APOTHEEK AMERY Nieuwpoort €514,486 €222,342 44.2% 1.8
Apotheek DK Bruges €465,446 €238,854 51.5% 1.8
BLAUWBLOMME Kortrijk €559,420 €209,566 -49.3% 1.8
APOTHEEK CANDIDE JACOBS De Haan €515,835 €238,048 15.8% 2.6

These companies have the same main activity as ALMAPHARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €465,000 and €565,000, founded between 1984 and 1991.

Official details

Source: KBO
Status
Active since 22-08-1985Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.027.760.6508660 De Panne, since 01-07-1985
Financial year end
31 December
Peppol
Reachable since 24-09-2025
Company details

Annual accounts 2025

€515,565▲ 36.1%
Employeeson 31-12-2025
3=
Filing
Filed on 07-04-2026, 115 days before the end of the filing period
Financials

Insights on ALMAPHARMA

ALMAPHARMA files the abbreviated format. That format states no turnover. The gross margin rose from €78,369 in 2006 to €223,954 in 2025.

The balance sheet grew most from 2024 to 2025 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about ALMAPHARMA

What is the company number of ALMAPHARMA?
The company number of ALMAPHARMA is 0427.782.965. The VAT number is the same number with BE in front: BE 0427.782.965.
Where is ALMAPHARMA based?
The registered office is at De Pannelaan 15, 8660 De Panne.Company details
What does ALMAPHARMA do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of ALMAPHARMA?
ALMAPHARMA is a private limited company (BV).
When was ALMAPHARMA founded?
ALMAPHARMA was founded on 22-08-1985.
Is ALMAPHARMA still active?
Yes, ALMAPHARMA is an active enterprise in the KBO register.
How many employees does ALMAPHARMA have?
ALMAPHARMA had an average of 2.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does ALMAPHARMA fall under?
In its 2025 annual accounts, ALMAPHARMA states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of ALMAPHARMA?
The turnover in financial year 2025 is ≈ €1.1m. This figure is estimated from the gross margin of €223,954 and 43 comparable companies (NACE 477). It probably lies between €690,000 and €2.2m.
Is ALMAPHARMA profitable?
In financial year 2025, ALMAPHARMA made a profit of €28,272.
Where can I find the annual accounts of ALMAPHARMA?
ALMAPHARMA filed 39 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of ALMAPHARMA due?
ALMAPHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.